Top Biotech Leader Joins New Company K2 Therapeutics
A respected biotech leader, Dr. Frank Wang, now heads K2 Therapeutics, a new company aiming to bring new medicines to patients.
Dr. Frank Wang takes on a new challenge. He is the new Chief Executive Officer at K2 Therapeutics. This comes just weeks after he left his post at Legend Biotech.
K2 Therapeutics is a new company. It started in 2024. The company received $50 million to begin its work. This money came from MPM BioImpact, a major investor in life sciences. K2 Therapeutics plans to develop important new medicines.
Dr. Wang's move shows big changes in the biotech world. Experienced leaders are joining new ventures. These new companies aim to solve tough health problems. This means more research and more hope for new treatments.
Source: FierceBiotech
More from Biotech
